Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Regenerative medicine for repair & remodeling of the damaged CNS w/ Ira Pastor

  • Broadcast in Health
  • 0 comments
Faces of TBI

Faces of TBI

×  

Follow This Show

If you liked this show, you should follow Faces of TBI.
h:942153
s:10551325
archived

Join host Amy Zellmer as she speaks with Ira Pastor.

Ira Pastor - Chief Executive Officer – Bioquark Inc. (www.bioquark.com) - Over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development; Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions.

Mr. Pastor has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance); MBA, Temple University; BS, Pharmacy, Rutgers University; He is also a Board Member of RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project (http://www.reanima.tech), member of the Executive Council of the World Academy of Medical Science – WAMS (https://wams.online/our_team/ira-s-pastor/), and member of the World Economic Forum's Human Enhancement council (https://www.weforum.org/people/ira-pastor).

sponsored by: Minnesota Functional Neurology, DC

Comments

 comments